Virtus Fund Advisers, LLC Intercept Pharmaceuticals, Inc. Transaction History

Virtus Fund Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $18,281 - $31,674	1,459 New	1,459 $19,000
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $189,767 - $306,177	-15,542 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $904,544 - $1.13 Million	15,542	15,542 $908,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus Fund Advisers, LLC with notifications on news.